Skip to contentKLEIN JOSEPH III — ISIS PHARMACEUTICALS INC insider: 663 transactions · InsiderLensKLEIN JOSEPH III
- Director at NPS PHARMACEUTICALS INC · on record since Jan 19, 2006
- Director at ISIS PHARMACEUTICALS INC · on record since Jan 18, 2006
- Director at SAVIENT PHARMACEUTICALS INC · on record since May 30, 2006
- Director at OSI PHARMACEUTICALS INC · on record since Jun 16, 2006
- Director at BIOMARIN PHARMACEUTICAL INC · on record since Aug 17, 2006
- Former Director at CLINICAL DATA INC · on record since Oct 13, 2006
- as of May 22, 2007 at NPS PHARMACEUTICALS INC · on record since May 25, 2007
- Director at PDL BIOPHARMA, INC. · on record since Jul 31, 2007
- Director at GENAISSANCE PHARMACEUTICALS INC · on record since Jul 9, 2003
- Director at GUILFORD PHARMACEUTICALS INC · on record since Aug 18, 2003
- Director at CLINICAL DATA INC · on record since Oct 19, 2005
- Director at AKCEA THERAPEUTICS, INC. · on record since Sep 23, 2019
Insider trading activity of KLEIN JOSEPH III
- Transactions on record
- 663
- since Aug 18, 2003
- Open-market buys
- 91
- $886K
- Open-market sells
- 174
- $19.5M
- Companies traded
- 10
- last filing May 5, 2026
Figures computed from official regulatory filings — methodology.
Companies where KLEIN JOSEPH III has traded
- ISIS PHARMACEUTICALS INC365 tx · $20.2M · Jul 6, 2026
- AKCEA THERAPEUTICS, INC.3 tx · $53.1K · Oct 13, 2020
- SAVIENT PHARMACEUTICALS INC37 tx · $1.4M · Jul 21, 2010
- OSI PHARMACEUTICALS INC62 tx · $4.3M · Jun 9, 2010
- BIOMARIN PHARMACEUTICAL INC44 tx · $3.4M · Mar 10, 2010
- PDL BIOPHARMA, INC.63 tx · $578.8K · Nov 6, 2009
- NPS PHARMACEUTICALS INC49 tx · $154.6K · May 25, 2007
- CLINICAL DATA INC5 tx · $87.6K · Oct 13, 2006
- GENAISSANCE PHARMACEUTICALS INC13 tx · Oct 6, 2005
Track record of KLEIN JOSEPH III
Statistical track record
Free- Open-market buys
- 91
- Last buy
- Feb 1, 2010
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of KLEIN JOSEPH III
Co-insiders of KLEIN JOSEPH III
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
28 tx · Jul 6, 2005
Jenne KyleAKCEA THERAPEUTICS, INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 6, 2026 | Exercise | 11,518 | 39.94 USD | — | SEC |
| Jul 6, 2026 | AwardD | 2,301 | 0.00 USD | — | SEC |
| Jul 6, 2026 | ExerciseD | -11,518 | 0.00 USD | — | SEC |
| Jul 6, 2026 | Sell | -11,419 | 79.04 USD | — | SEC |
| Jul 6, 2026 | AwardD | 5,369 | 0.00 USD | — | SEC |
| Jul 6, 2026 | Sell | -99 | 79.45 USD | — | SEC |
| May 5, 2026 | Exercise | 10,111 | 47.11 USD | $476.3K | SEC |
| May 5, 2026 | Sell | -8,680 | 73.35 USD | $636.7K | SEC |
| May 5, 2026 | ExerciseD | -10,111 | 0.00 USD | $0 | SEC |
| May 5, 2026 | Sell | -1,431 | 74.45 USD | $106.5K | SEC |
| Apr 2, 2026 | Exercise | 10,321 | 41.08 USD | $424K | SEC |
| Apr 2, 2026 | Sell | -2,216 | 75.95 USD | $168.3K | SEC |
| Apr 2, 2026 | ExerciseD | -10,321 | 0.00 USD | $0 | SEC |
| Apr 2, 2026 | Sell | -20,105 | 75.50 USD | $1.5M | SEC |
| Apr 2, 2026 | ExerciseD | -12,000 | 0.00 USD | $0 | SEC |
| Apr 2, 2026 | Exercise | 12,000 | 38.06 USD | $456.7K | SEC |
| Mar 5, 2026 | Sell | -13,526 | 79.17 USD | $1.1M | SEC |
| Mar 5, 2026 | Sell | -6,794 | 80.00 USD | $543.5K | SEC |
| Mar 5, 2026 | ExerciseD | -4,000 | 0.00 USD | $0 | SEC |
| Mar 5, 2026 | Exercise | 12,000 | 40.05 USD | $480.6K | SEC |
| Mar 5, 2026 | ExerciseD | -12,000 | 0.00 USD | $0 | SEC |
| Mar 5, 2026 | Sell | -1,012 | 80.82 USD | $81.8K | SEC |
| Mar 5, 2026 | Exercise | 4,000 | 42.88 USD | $171.5K | SEC |
| Nov 28, 2025 | Sell | -4,000 | 80.00 USD | $320K | SEC |
| Nov 28, 2025 | Sell | -4,000 | 80.00 USD | $320K | SEC |